ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,385Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 288

$544K Total Retail Price of All Prescriptions

Rank: 59 out of 288

471 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 9,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 605 525 1 2
SIMVASTATIN 474 429 2 1
HYDROCODONE-ACETAMINOPHEN 426 329 S3 3 7
AMLODIPINE BESYLATE 416 370 4 6
OMEPRAZOLE 375 323 5 3
POTASSIUM CHLORIDE 356 305 6 11
WARFARIN SODIUM 317 258 7 9
ALENDRONATE SODIUM 288 271 8 20
FUROSEMIDE 237 198 9 5
ZOLPIDEM TARTRATE 225 150 10 22
METOPROLOL TARTRATE 158 152 11 8
ATORVASTATIN CALCIUM 156 142 12 14
LOSARTAN POTASSIUM 139 128 13 16
LISINOPRIL 136 125 14 4
TRAMADOL HCL 134 102 15 19
CLONIDINE HCL 126 105 16 70
GLYBURIDE 125 94 R 17 59
ATENOLOL 124 124 18 10
PANTOPRAZOLE SODIUM 122 112 19 42
GABAPENTIN 120 80 20 17
METFORMIN HCL 119 102 21 12
DIOVAN 113 101 22 53
METOPROLOL SUCCINATE 105 96 23 15
NEXIUM 105 101 23 43
CITALOPRAM HBR 102 94 25 18
LEVOFLOXACIN 98 90 26 80
HYDROCHLOROTHIAZIDE 87 76 27 13
OXYCODONE HCL-ACETAMINOPHEN 84 22 S2 28 255
ALLOPURINOL 80 51 29 23
AMITRIPTYLINE HCL 76 76 R 30 65
SYNTHROID 72 69 31 63
FENOFIBRATE 67 66 32 61
METHOCARBAMOL 67 19 R 32 232
VERAPAMIL ER 66 48 34 97
ZETIA 64 64 35 58
DONEPEZIL HCL 62 62 36 29
DILTIAZEM 24HR CD 61 48 37 75
TRIAMTERENE-HCTZ 60 60 38 28
DILTIAZEM ER 59 59 39 102
BENAZEPRIL HCL 58 58 40 52
OXYBUTYNIN CHLORIDE ER 57 57 41 116
DOXAZOSIN MESYLATE 56 45 42 78
LANTUS 56 19 42 31
CRESTOR 55 52 44 26
PREDNISONE 55 52 44 30
TAMSULOSIN HCL 54 46 46 24
DEMEROL 53 0 S2 R 47 342
PRAVASTATIN SODIUM 53 52 47 21
ENALAPRIL MALEATE 52 50 49 40
ISOSORBIDE MONONITRATE ER 51 28 50 35
SINGULAIR 50 38 51 86
NIFEDIPINE ER 50 50 51 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.